Company intelligence / Profile preview
Jiangsu Vcare Pharmatech Co., Ltd.
Nanjing, Jiangsu Province, 中国（China）en.vcarepharmatech.com ↗
- Ownership
- Private
- Development stage
- NDA
01
Overview
Jiangsu Vcare’s lead asset Vicagrel is a next-generation oral P2Y12 inhibitor designed to overcome clopidogrel resistance. It has completed Phase II studies in China with positive results and is in Phase III trials domestically while preparing for NDA submission in the US. Other pipeline assets include second-generation JAK1 inhibitors and NTRK inhibitors at various clinical stages. The company also has multiple preclinical programs targeting oncology, immunology, and inflammation[5][6][10].
- Therapeutic areas
- OncologyImmunologyCardiovascular
- Modalities
- Small moleculesPROTACs (Proteolysis-targeting chimeras)
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
Collaboration with China Pharmaceutical University on Vicagrel development[5].Strategic cooperation bases for phase I clinical study established nationwide in China[8].
Beyond the preview
Go deeper on Jiangsu Vcare Pharmatech Co., Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Jiangsu Vcare Pharmatech Co., Ltd..